top of page

GeneSight Testing

Gene Sight Testing is a groundbreaking genetic test that offers valuable insights into how an individual's genetic profile may impact their response to stimulant medications commonly prescribed for attention deficit hyperactivity disorder (ADHD). By examining specific genes involved in drug metabolism and neurotransmitter pathways, Gene Sight Testing enables healthcare professionals to make more informed decisions when selecting stimulant medications for ADHD treatment. This personalized approach can significantly improve treatment outcomes by identifying stimulants that are more likely to be effective and minimizing the risk of adverse reactions. Gene Sight Testing empowers both patients and clinicians by providing a comprehensive understanding of how genetic factors may influence the selection of stimulant medications, leading to more targeted and individualized ADHD care.

bottom of page